Exhibit 5.1
Our ref ELR/754076-000010/18609127v2
Burning Rock Biotech Limited
601, 6/F, Building 3, Standard Industrial Unit 2
No. 7, Luoxuan 4th Road
International Bio Island, Guangzhou, 510005
People’s Republic of China
1 December 2020
Dear Sirs
Burning Rock Biotech Limited
We have acted as Cayman Islands legal advisers to Burning Rock Biotech Limited (the “Company”) in connection with the Company’s registration statement on Form F-1, including all amendments or supplements thereto (the “Registration Statement”), filed with the Securities and Exchange Commission under the U.S. Securities Act of 1933, as amended to date relating to the offering by the Company of certain American depositary shares (the “ADSs”) representing the Company’s class A ordinary shares of par value US$0.0002 each (the “Shares”).
We are furnishing this opinion as Exhibits 5.1, 8.1 and 23.2 to the Registration Statement.
For the purposes of this opinion, we have reviewed only originals, copies or final drafts of the following documents:
1.1 | The certificate of incorporation of the Company dated 6 March 2014 issued by the Registrar of Companies in the Cayman Islands. |
1.2 | The tenth amended and restated memorandum and articles of association of the Company as conditionally adopted by a special resolution passed on 31 January 2020 and effective immediately prior to the completion of the Company’s initial public offering of the ADSs representing its Shares (the “Memorandum and Articles”). |
1.3 | The written resolutions of the directors of the Company dated 30 November 2020 (the “Directors’ Resolutions”). |
1.4 | A certificate from a director of the Company, a copy of which is attached hereto (the “Director’s Certificate”). |
1.5 | A certificate of good standing with respect to the Company issued by the Registrar of Companies dated 12 November 2020 (the “Certificate of Good Standing”). |
1.6 | The Registration Statement. |